> top > docs > PMC:3586680 > spans > 21-302 > annotations

PMC:3586680 / 21-302 JSONTXT

Annnotations TAB JSON ListView MergeView

test3

Id Subject Object Predicate Lexical cue
T42 5-8 Protein denotes p53
T60 5-8 Protein denotes p53
T64 273-276 Protein denotes FOR
T63 267-271 Protein denotes WWOX
T62 231-266 Protein denotes WW domain-containing oxidoreductase
T61 85-88 Protein denotes p53
T46 273-276 Protein denotes FOR
T45 267-271 Protein denotes WWOX
T44 231-266 Protein denotes WW domain-containing oxidoreductase
T43 85-88 Protein denotes p53
R5 T63 T64 themeOf WWOX,FOR
R6 T64 T62 equivalentTo FOR,WW domain-containing oxidoreductase

testone

Id Subject Object Predicate Lexical cue
T20 5-8 Protein denotes p53
T24 273-276 Protein denotes FOR
T23 267-271 Protein denotes WWOX
T22 231-266 Protein denotes WW domain-containing oxidoreductase
T21 85-88 Protein denotes p53

bionlp-st-ge-2016-test-tees

Id Subject Object Predicate Lexical cue
T475 5-8 Protein denotes p53
T478 273-276 Protein denotes FOR
T477 252-271 Protein denotes oxidoreductase WWOX
T476 85-88 Protein denotes p53

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T555 1-4 CC denotes and
T556 5-8 NN denotes p53
T557 9-20 NNS denotes Alterations
T558 21-24 CC denotes and
T559 25-29 NN denotes Drug
T560 30-40 NN denotes Resistance
T561 41-43 IN denotes in
T562 44-57 NNP denotes Glioblastomas
T599 277-279 CC denotes or
T598 273-276 IN denotes FOR
T597 272-273 -LRB- denotes (
T596 267-271 NNP denotes WWOX
T595 252-266 NN denotes oxidoreductase
T594 234-251 JJ denotes domain-containing
T593 231-233 NNP denotes WW
T592 229-230 . denotes .
T591 224-229 NNS denotes drugs
T590 212-223 JJ denotes therapeutic
T589 208-211 CC denotes and
T588 206-207 -RRB- denotes )
T587 203-206 NNP denotes TMZ
T586 202-203 -LRB- denotes (
T585 189-201 VB denotes temozolomide
T584 186-188 TO denotes to
T583 175-185 NN denotes resistance
T582 172-174 TO denotes to
T581 170-171 , denotes ,
T580 166-170 NN denotes part
T579 163-165 IN denotes in
T578 161-162 , denotes ,
T577 151-161 VB denotes contribute
T576 148-150 TO denotes to
T575 140-147 VBZ denotes appears
T574 136-139 CC denotes and
T573 134-135 -RRB- denotes )
T572 130-134 NNS denotes GBMs
T571 129-130 -LRB- denotes (
T570 115-128 NNS denotes glioblastomas
T569 112-114 IN denotes in
T568 104-111 VBN denotes mutated
T567 93-103 RB denotes frequently
T566 89-92 VBP denotes are
T565 85-88 NN denotes p53
T564 74-84 NN denotes suppressor
T563 68-73 NNP denotes Tumor
R269 T556 T557 compound p53,Alterations
R271 T558 T557 cc and,Alterations
R272 T559 T560 compound Drug,Resistance
R273 T560 T557 conj Resistance,Alterations
R274 T561 T557 prep in,Alterations
R275 T562 T565 compound Glioblastomas,p53
R276 T563 T565 compound Tumor,p53
R277 T564 T565 compound suppressor,p53
R278 T565 T561 pobj p53,in
R279 T566 T568 auxpass are,mutated
R280 T567 T568 advmod frequently,mutated
R281 T568 T568 ROOT mutated,mutated
R282 T569 T568 prep in,mutated
R283 T570 T569 pobj glioblastomas,in
R284 T571 T572 punct (,GBMs
R285 T572 T570 appos GBMs,glioblastomas
R286 T573 T568 punct ),mutated
R287 T574 T568 cc and,mutated
R288 T575 T568 conj appears,mutated
R289 T576 T577 aux to,contribute
R290 T577 T575 xcomp contribute,appears
R291 T578 T577 punct ",",contribute
R292 T579 T575 prep in,appears
R293 T580 T579 pobj part,in
R294 T581 T575 punct ",",appears
R295 T582 T583 aux to,resistance
R296 T583 T568 advcl resistance,mutated
R297 T584 T585 aux to,temozolomide
R298 T585 T583 advcl temozolomide,resistance
R299 T586 T587 punct (,TMZ
R300 T587 T585 appos TMZ,temozolomide
R301 T588 T587 punct ),TMZ
R302 T589 T585 cc and,temozolomide
R303 T590 T591 amod therapeutic,drugs
R304 T591 T585 conj drugs,temozolomide
R305 T592 T568 punct .,mutated
R306 T593 T596 compound WW,WWOX
R307 T594 T596 compound domain-containing,WWOX
R308 T595 T596 compound oxidoreductase,WWOX
R310 T597 T598 punct (,FOR
R311 T598 T596 prep FOR,WWOX
R312 T599 T598 cc or,FOR

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T546 5-8 Protein denotes p53
T537 231-266 Protein denotes WW domain-containing oxidoreductase
T535 189-207 Entity denotes temozolomide (TMZ)
T532 231-271 Protein denotes WW domain-containing oxidoreductase WWOX
T526 212-229 Entity denotes therapeutic drugs
T525 68-88 Protein denotes Tumor suppressor p53
T523 203-206 Entity denotes TMZ

DLUT931

Id Subject Object Predicate Lexical cue
T398 5-8 Protein denotes p53
T415 9-20 Regulation denotes Alterations
T402 273-276 Protein denotes FOR
T401 267-271 Protein denotes WWOX
T400 231-266 Protein denotes WW domain-containing oxidoreductase
T399 85-88 Protein denotes p53
R213 T398 T415 themeOf p53,Alterations

BioNLP16_Messiy

Id Subject Object Predicate Lexical cue
T448 5-8 Protein denotes p53
T465 9-20 Regulation denotes Alterations
T452 273-276 Protein denotes FOR
T451 267-271 Protein denotes WWOX
T450 231-266 Protein denotes WW domain-containing oxidoreductase
T449 85-88 Protein denotes p53
R230 T448 T465 themeOf p53,Alterations

BioNLP16_DUT

Id Subject Object Predicate Lexical cue
T356 5-8 Protein denotes p53
T360 273-276 Protein denotes FOR
T359 267-271 Protein denotes WWOX
T358 231-266 Protein denotes WW domain-containing oxidoreductase
T357 85-88 Protein denotes p53

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T390 5-8 http://www.uniprot.org/uniprot/P04637 denotes p53
T396 68-88 http://www.uniprot.org/uniprot/P04637 denotes Tumor suppressor p53
T391 85-88 http://www.uniprot.org/uniprot/P04637 denotes p53
T388 273-276 http://www.uniprot.org/uniprot/Q9NZC7 denotes FOR
T382 267-271 http://www.uniprot.org/uniprot/Q9NZC7 denotes WWOX

bionlp-st-ge-2016-test-proteins

Id Subject Object Predicate Lexical cue
T119 5-8 Protein denotes p53
T120 85-88 Protein denotes p53
T121 231-266 Protein denotes WW domain-containing oxidoreductase
T122 267-271 Protein denotes WWOX
T123 273-276 Protein denotes FOR

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T169 1-4 CC denotes and
T170 5-8 NN denotes p53
T171 9-20 NN denotes Alterations
T172 21-24 CC denotes and
T173 25-29 NNP denotes Drug
T174 30-40 NNP denotes Resistance
T175 41-43 IN denotes in
T176 44-57 NN denotes Glioblastomas
T212 277-279 CC denotes or
T211 273-276 NN denotes FOR
T210 272-273 -LRB- denotes (
T209 267-271 NN denotes WWOX
T208 252-266 NN denotes oxidoreductase
T207 234-251 JJ denotes domain-containing
T206 231-233 JJ denotes WW
T205 224-229 NN denotes drugs
T204 212-223 JJ denotes therapeutic
T203 208-211 CC denotes and
T202 206-207 -RRB- denotes )
T201 203-206 NN denotes TMZ
T200 202-203 -LRB- denotes (
T199 189-201 NN denotes temozolomide
T198 186-188 TO denotes to
T197 175-185 NN denotes resistance
T196 172-174 TO denotes to
T195 170-171 -COMMA- denotes ,
T194 166-170 NN denotes part
T193 163-165 IN denotes in
T192 161-162 -COMMA- denotes ,
T191 151-161 VB denotes contribute
T190 148-150 TO denotes to
T189 140-147 VB denotes appears
T188 136-139 CC denotes and
T187 134-135 -RRB- denotes )
T186 130-134 NN denotes GBMs
T185 129-130 -LRB- denotes (
T184 115-128 NN denotes glioblastomas
T183 112-114 IN denotes in
T182 104-111 VB denotes mutated
T181 93-103 RB denotes frequently
T180 89-92 VB denotes are
T179 85-88 NN denotes p53
T178 74-84 NN denotes suppressor
T177 68-73 NN denotes Tumor
R31 T169 T175 arg1Of and,in
R32 T171 T170 arg1Of Alterations,p53
R33 T171 T172 arg1Of Alterations,and
R34 T172 T169 arg2Of and,and
R35 T174 T172 arg2Of Resistance,and
R36 T174 T173 arg1Of Resistance,Drug
R37 T176 T175 arg2Of Glioblastomas,in
R38 T179 T177 arg1Of p53,Tumor
R39 T179 T178 arg1Of p53,suppressor
R40 T179 T180 arg1Of p53,are
R41 T179 T182 arg2Of p53,mutated
R42 T179 T189 arg1Of p53,appears
R43 T179 T191 arg1Of p53,contribute
R44 T182 T180 arg2Of mutated,are
R45 T182 T181 arg1Of mutated,frequently
R46 T182 T183 arg1Of mutated,in
R47 T182 T188 arg1Of mutated,and
R48 T184 T183 arg2Of glioblastomas,in
R49 T184 T185 arg1Of glioblastomas,(
R50 T186 T185 arg2Of GBMs,(
R51 T187 T185 arg3Of ),(
R52 T189 T188 arg2Of appears,and
R53 T191 T189 arg2Of contribute,appears
R54 T191 T190 arg1Of contribute,to
R55 T191 T192 arg1Of contribute,","
R56 T191 T193 arg1Of contribute,in
R57 T191 T195 arg1Of contribute,","
R58 T191 T196 arg1Of contribute,to
R59 T194 T193 arg2Of part,in
R60 T197 T198 arg1Of resistance,to
R61 T197 T203 arg1Of resistance,and
R62 T199 T198 arg2Of temozolomide,to
R63 T199 T200 arg1Of temozolomide,(
R64 T201 T200 arg2Of TMZ,(
R65 T202 T200 arg3Of ),(
R66 T203 T196 arg2Of and,to
R67 T205 T203 arg2Of drugs,and
R68 T205 T204 arg1Of drugs,therapeutic
R69 T209 T206 arg1Of WWOX,WW
R70 T209 T207 arg1Of WWOX,domain-containing
R71 T209 T208 arg1Of WWOX,oxidoreductase
R72 T209 T210 arg1Of WWOX,(
R76 T211 T212 arg1Of FOR,or
R77 T212 T210 arg2Of or,(

GO-BP

Id Subject Object Predicate Lexical cue
T139 25-40 http://purl.obolibrary.org/obo/GO_0042493 denotes Drug Resistance
T137 68-84 http://purl.obolibrary.org/obo/GO_0051726 denotes Tumor suppressor

sentences

Id Subject Object Predicate Lexical cue
T80 68-230 Sentence denotes Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs.
T2 59-67 Sentence denotes Abstract
T3 68-230 Sentence denotes Tumor suppressor p53 are frequently mutated in glioblastomas (GBMs) and appears to contribute, in part, to resistance to temozolomide (TMZ) and therapeutic drugs.

simple1

Id Subject Object Predicate Lexical cue
T149 5-8 Protein denotes p53
T153 273-276 Protein denotes FOR
T152 267-271 Protein denotes WWOX
T151 231-266 Protein denotes WW domain-containing oxidoreductase
T150 85-88 Protein denotes p53